Read More Pharma Industry News Phase 2 trial of Nasus Pharma’s NS002 needle-free epinephrine starts with initial dosing milestone Find out how Nasus Pharma is advancing NS002, its needle-free intranasal epinephrine candidate, into Phase 2 trials and what it means for emergency allergy care. bySoujanya RaviNovember 18, 2025